A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis
published in: Arthritis & Rheumatology
date of publication: 2017-03-03
Cites articles 30
- 2003-07-10
- 1993-04-01
Date
Title
Article - wd:Q40353912